Press releases | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Press releases

PRESS RELEASE

published on 02/03/2026 at 07:29, 7 months 9 days ago

Publicis Groupe : Résultats annuels 2025
PRESS RELEASE

published on 02/03/2026 at 07:29, 7 months 9 days ago

Publics Groupe: Full Year 2025 Results
PRESS RELEASE

published on 02/03/2026 at 07:25, 7 months 9 days ago

Elevating Trust: Fox ESS Grand Gala 2026 Welcomes Over 300 Global Partners
Fox ESS hosted the Grand Gala 2026, welcoming over 300 global partners to explore clean energy and strengthen collaborations. Remarkable growth and market achievements

Sustainable Future Clean Energy Global Partnerships Fox ESS Grand Gala 2026
PRESS RELEASE

published on 02/03/2026 at 07:15, 7 months 9 days ago

Sartorius Stedim Biotech réalise une croissance rentable importante en 2025 et maintient des perspectives positives
Sartorius Stedim Biotech réalise une croissance rentable en 2025 avec un chiffre d'affaires en hausse de 9,6 %. Perspectives positives pour 2026

Chiffre D'affaires Sartorius Stedim Biotech Croissance Rentable Perspectives 2026
PRESS RELEASE

published on 02/03/2026 at 07:00, 7 months 9 days ago

Siltronic AG with preliminary financial figures: Targets for 2025 achieved despite challenging conditions
Siltronic AG achieves 2025 targets with preliminary financial figures despite challenging conditions. Sales at EUR 1,347 million with 4.7% decline. EBITDA margin reaches 23.5%

EBITDA Margin Preliminary Financial Figures Sales Decline Siltronic AG 2025 Targets
PRESS RELEASE

published on 02/03/2026 at 07:00, 7 months 9 days ago

Sartorius Stedim Biotech réalise une croissance rentable importante en 2025 et maintient des perspectives positives
Sartorius Stedim Biotech réalise une croissance rentable en 2025 et maintient des perspectives positives. Chiffre d'affaires en hausse de 9,6% à taux de change constants. EBITDA à 914 millions d'euros. Perspectives de croissance rentable pour 2026

Chiffre D'affaires EBITDA Sartorius Stedim Biotech Croissance Rentable Perspectives Positives
PRESS RELEASE

published on 02/03/2026 at 07:00, 7 months 9 days ago

Sartorius Stedim Biotech achieves considerable profitable growth in 2025 and maintains positive outlook
Sartorius Stedim Biotech achieves significant profitable growth in 2025 with unaudited sales revenue up 9.6% in constant currencies. Management expects continued growth in 2026

Financial Results Sartorius Stedim Biotech Profitable Growth 2025 2026
PRESS RELEASE

published on 02/03/2026 at 07:00, 7 months 9 days ago

Medacta Group SA: Medacta Group reports continued significant above-market revenue growth of 18.5% in constant currency in 2025
Medacta Group SA reports 18.5% revenue growth in 2025, with strong performance in all geographic markets and business lines. New jobs created to drive further expansion

Revenue Growth Business Lines Medacta Group SA 2025 Geographic Markets
PRESS RELEASE

published on 02/03/2026 at 07:00, 7 months 9 days ago

Sartorius achieves considerable profitable growth in 2025 and maintains positive outlook
Sartorius achieves considerable profitable growth in 2025 with a 7.6% increase in sales revenue to around 3.5 billion euros. Positive outlook maintained for 2026

Sartorius Profitable Growth Sales Revenue Positive Outlook 2026
PRESS RELEASE

published on 02/03/2026 at 07:00, 7 months 9 days ago

Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia
Newron Pharmaceuticals S.p.A. announces publication highlighting Evenamide as adjunctive treatment in schizophrenia. Scientific evidence supports unique approach

Schizophrenia Publication Newron Pharmaceuticals Evenamide Adjunctive Treatment

Accesswire

Published on 09/12/2026 at 02:35, 13 hours 59 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 17 hours 34 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 18 hours 29 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 19 hours 9 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 23 hours 34 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 9 hours 3 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 18 hours 18 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 18 hours 23 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 20 hours 49 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 22 hours 18 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 9 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 9 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 9 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 9 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 21 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE